VR Logo

Enveric Biosciences Inc. (ENVB) download report


Healthcare | Biotechnology & Pharma Research

Enveric Biosciences Inc. (ENVB) Premium Coverage

53 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care.

IPO Date: 24-Jun-2015

Exec. Chairman: Mr. David Ian Johnson

CEO & Director: Dr. Joseph Edward Tucker Ph.D.

Listing: NASDAQ: ENVB

Country: United States

Headquarters: Naples, FL

Website: https://www.enveric.com

Key Facts

Market cap: $9.34 Mln

Revenue (TTM): $0.00 Mln

Earnings (TTM): $-50.25 Mln

Cash: $21.69 Mln

Total Debt: $0.15 Mln

Insider's Holding: 26.87%

Liquidity: Low

52 Week range: $5.90 - 187.00

Shares outstanding: 1,286,540

10 Years Aggregate:

  • CFO: $-29.57 Mln
  • EBITDA: $-55.66 Mln
  • Net Profit: $-92.15 Mln

Stock Performance

Time Period Enveric Biosciences (ENVB) S&P BSE Sensex* S&P Small-Cap 600*
YTD-84.390.97-11.58
1 month-31.838.568.86
3 months-42.157.26-2.19
1 Year-92.288.36-6.23
3 Years-82.8517.039.73
5 Years-81.3912.757.72
10 Years-38.7012.8210.81
As on 05-Aug-2022 *As on 08-Aug-2022
Year Enveric Biosciences (ENVB) S&P Small-Cap 600 S&P BSE Sensex
2021-78.1725.2721.99
2020-52.889.5715.75
2019-48.1720.8614.38
2018-94.29-9.705.87
2017-52.3811.7327.91
2016-1.3624.741.95
2015581.48-3.36-5.03